Related Experiment Videos
A predominant idiotype in the gut associated lymphoid tissue
1Laboratoire de Microbiology, Faculte de Medecine, Rennes, France.
Advances in Experimental Medicine and Biology
|January 1, 1987
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Activation of MHC class I, II, and CD40 gene expression by histone deacetylase inhibitors.
Journal of immunology (Baltimore, Md. : 1950)·2000
Chromatin-immune connections: regulation of MHC and other genes.
Journal of reproductive immunology·2000
Effect of transforming growth factor-beta1 on microglial MHC-class II expression.
Journal of neuroimmunology·2000
Absence of MHC class II antigen expression in trophoblast cells results from a lack of class II transactivator (CIITA) gene expression.
Molecular reproduction and development·1998
Role of transforming growth factor-beta1 in the suppressed allostimulatory function of AIDS patients.
AIDS (London, England)·1998
Nucleoskeletal Proteins in Early Embryogenesis.
Advances in experimental medicine and biology·2026
Nuclear Dynamics and Its Timing Regulation Revealed by Live-Cell Imaging.
Advances in experimental medicine and biology·2026
Histone Modifications in Mammalian Early Embryos.
Advances in experimental medicine and biology·2026
Oocyte Kinetochores at the Nexus of Meiotic Drive and Segregation Fidelity.
Advances in experimental medicine and biology·2026
Asymmetric Chromosome Establishment and Segregation During Germline Stem Cell Division.
Advances in experimental medicine and biology·2026
Non-random Sister Chromatid Segregation Mediated by Ribosomal DNA in Drosophila Male Germline Stem Cells.
Advances in experimental medicine and biology·2026
Lung biopsy strategies for childhood interstitial lung disease: Indications and techniques.
The Journal of international medical research·2026
"I know how important it is": A qualitative analysis of participants' experiences in a vaccine safety study.
Human vaccines & immunotherapeutics·2026